- Home
- CLMT vs AAPG Comparison
CLMT vs AAPG Comparison
Compare CLMT & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLMT
- AAPG
- Stock Information
- Founded
- CLMT 1916
- AAPG 2009
- Country
- CLMT United States
- AAPG China
- Employees
- CLMT N/A
- AAPG N/A
- Industry
- CLMT Oil & Gas Production
- AAPG Biotechnology: Pharmaceutical Preparations
- Sector
- CLMT Energy
- AAPG Health Care
- Exchange
- CLMT Nasdaq
- AAPG Nasdaq
- Market Cap
- CLMT 1.4B
- AAPG 1.7B
- IPO Year
- CLMT 2006
- AAPG 2025
- Fundamental
- Price
- CLMT $13.16
- AAPG $21.65
- Analyst Decision
- CLMT Strong Buy
- AAPG Buy
- Analyst Count
- CLMT 5
- AAPG 1
- Target Price
- CLMT $22.80
- AAPG N/A
- AVG Volume (30 Days)
- CLMT 1.4M
- AAPG 24.9K
- Earning Date
- CLMT 05-09-2025
- AAPG 03-27-2025
- Dividend Yield
- CLMT N/A
- AAPG N/A
- EPS Growth
- CLMT N/A
- AAPG N/A
- EPS
- CLMT N/A
- AAPG N/A
- Revenue
- CLMT $4,189,399,999.00
- AAPG $134,352,180.00
- Revenue This Year
- CLMT N/A
- AAPG $328.14
- Revenue Next Year
- CLMT N/A
- AAPG N/A
- P/E Ratio
- CLMT N/A
- AAPG N/A
- Revenue Growth
- CLMT 0.20
- AAPG 341.77
- 52 Week Low
- CLMT $9.97
- AAPG $16.50
- 52 Week High
- CLMT $25.29
- AAPG $22.43
- Technical
- Relative Strength Index (RSI)
- CLMT 47.70
- AAPG N/A
- Support Level
- CLMT $11.91
- AAPG N/A
- Resistance Level
- CLMT $13.51
- AAPG N/A
- Average True Range (ATR)
- CLMT 0.77
- AAPG 0.00
- MACD
- CLMT 0.27
- AAPG 0.00
- Stochastic Oscillator
- CLMT 88.41
- AAPG 0.00
About CLMT Calumet Specialty Products Partners L.P. Common Units
Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets.
About AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The company's geographical segments include the United States and Mainland China.